Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.023 | 0.7 |
mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | GDC-0449 | FIMM | pan-cancer | AAC | 0.071 | 0.7 |